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Thinning of retinal layers, measured using optical coherence tomography 
(OCT), is associated with some neurodegenerative disorders such as 
established Alzheimer’s disease and multiple sclerosis. The evidence for 
retinal layer thinning in both mild cognitive impairment (MCI), a precursor 
of dementia, and delirium, a potential pre-clinical stage of 
neurodegenerative disorder, is unclear. We performed a systematic 
review of the associations, in older people, between retinal layer thickness 
changes (measured using OCT) and delirium or MCI compared to controls 
(Protocol registration ID (Prospero) CRD42019122165). We did not 
identify any relevant studies on delirium. This report is therefore a review 
of retinal nerve layer changes in mild cognitive impairment. Databases 
were searched using predetermined keywords such as mild cognitive 
impairment, retinal nerve fibre layer and delirium. Where there were 
sufficient data, meta-analyses were performed. Twenty-six relevant 
studies were identified on retinal layer thickness in people with MCI 
compared to controls. There was significant heterogeneity in the studies 
for all retinal layers investigated (retinal nerve fibre layer (RNFL), 
ganglion cell inner plexiform layer (GCIP), foveal thickness and macular 
volume). Analysis of 17 studies of mean RNFL thickness in MCI (n = 622) 
compared to controls (n = 1154), irrespective of the type of OCT device, 
demonstrated a significant thinning in MCI (SMD: – 0·42 and 95% 
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confidence interval: - 0·68 to - 0·16). This difference was non-significant 
when studies using only spectral-domain devices were analysed. 
Subgroup analysis of studies using spectral-domain devices in amnestic 
MCI diagnosed using comparable criteria, showed statistically significant 
thinning of RNFL in amnestic MCI (p = 0·02). Meta-analysis of foveal 
thickness did not show a significant difference between MCI and controls. 
In conclusion, there is some evidence of an association between retinal 
nerve fibre layer thinning and MCI. We found no data on the association 






In the UK, approximately 12 million people are greater than 65 years old 
and the size of this age group is increasing faster than those under 65 
years.1 Whilst modern medicine is helping us live longer, the 
improvement in longevity leaves us with the challenge of preserving 
quality of life and providing excellent standards of care to an ageing 
population. Mild cognitive impairment (MCI), i.e. cognitive impairment 
with minimal impairment of instrumental activities of daily living, provides 
one such challenge. The prevalence of MCI is estimated as 8.4% for 
people aged 65 – 69 years, increasing up to 25.2% for those in the 80 – 
84 years age group.2  
The term ‘mild cognitive impairment’ includes several subtypes of 
heterogeneous aetiology and consequences.3,4 The range of diagnostic 
criteria of MCI used by researchers includes Petersen’s criteria, Winblad 
criteria, NIA-AA clinical criteria, and NIA-AA research criteria amongst 
others. The amnestic subtype of MCI is more tightly defined and has a 
more predictable association with subsequent Alzheimer’s disease with a 
conversion rate of around 10 - 12% per year.5 However, even within this 
diagnostic category there is some variability in reported outcomes.6,7 
Histopathological findings of increased neurofibrillary tangles in the 
neocortex and amygdala, suggestive of early Alzheimer’s disease, raises 
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the possibility of pathological commonalities between amnestic MCI and 
Alzheimer’s disease.8  
Optical coherence tomography (OCT) is a non-invasive method of 
acquiring cross-sectional images of tissues which has evolved over the 
years.9 The newer generation spectral-domain device produces higher 
resolution images in a shorter time than the older, time-domain OCT 
devices. However, both types are still currently used in clinically practice.  
In Alzheimer’s disease an association with thinning of the retinal nerve 
fibre layer (RNFL), measured using OCT, has been described.10-12  
In view of this, and the association between thinning of the RNFL and 
other neurodegenerative conditions such as Parkinson’s disease13 and 
multiple sclerosis,14 several investigators have explored the possibility of 
an association between retinal layer thinning and MCI. The results of 
these studies have been conflicting, perhaps due to differences in study 
design, OCT device used, patient selection, variable implementation of a 
number of diagnostic criteria of MCI, and other factors. In an attempt to 
achieve clarity from the available studies, some authors have conducted 
systematic reviews and meta-analyses where sufficient data were 
available, but again with conflicting results. A recent report, which 
included a meta-analysis of seven studies (198 MCI eyes and 309 control 
eyes) on mean RNFL thickness (measured using spectral-domain OCT) 
and MCI, demonstrated non-significant thinning of mean RNFL in MCI 
participants.12 However, the review by Thomson et al, of five studies (214 
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MCI eyes and 421 control eyes) using either time-domain (three studies) 
or spectral-domain OCT (two studies) devices, showed a statistically 
significant thinning of the mean RNFL in MCI compared to controls (p = 
0.005).11 On subgroup analysis, based on type of OCT device used, the 
significant thinning was present only in studies which used time domain 
OCT devices. In Coppola et al’s review, meta-analysis of three studies 
which used time-domain OCT devices to measure mean RNFL revealed a 
significant thinning, p < 0·0001, associated with MCI (68 patients) 
compared to controls (80 patients).10 Close scrutiny of the studies 
included in the reviews showed that while most were on amnestic MCI, at 
least four different diagnostic criteria of MCI were used.  
Currently, clinical diagnosis of MCI is based on interviews and 
neurocognitive tests. A reliable, quick, consistent and simple screening 
tool may radically improve timely diagnosis and management.  
Objectives 
A systematic review to identify and evaluate the literature on the 
thickness of the different retinal layers, as measured by OCT, in people 
with MCI compared to controls. We also aimed to review the literature on 
the thickness of different retinal layers, as measured by OCT, in delirium 
compared to controls. We were unable to identify any studies on OCT and 
delirium that fulfilled our a priori criteria. Additional subgroup analysis on 
studies including only people with amnestic MCI was performed. We 
analysed each layer e.g. RNFL, ganglion cell inner plexiform layer (GCIP) 
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etc., independently. Meta-analyses were performed where there were a 
sufficient amount of homogenous data.  
Methods 




Preferred reporting items for systematic reviews and meta-analysis 
(PRISMA) guidelines15 were used in structuring this report. 
Eligibility criteria  
Original studies published in peer reviewed journals which compared 
retinal layer thickness in people with delirium or MCI to controls were 
included. The original protocol included participants aged ≥ 65 years old 
but because of the variability in the methods used to report age in the 
studies identified, a mean age of ≥ 65 years was used. Other 
requirements for inclusion were 1) clear diagnostic criteria for delirium or 
MCI, 2) stated brand of OCT device used, 3) a control group and 4) 
availability of full text article. Exclusions included review articles, absence 
of evidence of retinal screening (history +/- ophthalmologic examination) 
for confounders such as glaucoma and age related macular degeneration, 
duplicate reporting and studies on cognitive impairment no dementia 





Initially a search of databases of systematic reviews was conducted to 
assess existing reviews and meta-analysis on OCT and delirium or MCI. 
Databases searched included the Database of Abstracts of Reviews of 
Effects (DARE), Cochrane database of systematic reviews, PubMed 
reviews, Medline reviews, National Institute of Clinical Excellence (NICE) 
evidence, Joanna Briggs Institute (JBI) database of systematic reviews 
and implementation report, and Prospero international prospective 
register of systematic reviews. We found no pre-existing reviews on OCT 
and delirium. Regarding MCI, reviews identified had a limited number of 
studies on MCI and OCT11,12,17 or were largely focussed on retinal layers in 
Alzheimer’s disease with MCI as a secondary subject.11,18-20 
Current review  
A literature search was conducted by two independent researchers (A.N. 
and D.A.). Databases queried were Medline, EMBASE, PubMed, Scopus, 
CINAHL, Cochrane, PsycINFO, Web of Science and TRIP. Chosen search 
dates (1991 for delirium and 1995 for MCI, both until March 2019) were 
based on the first description of OCT9 and Petersen’s original definition of 
MCI.21 The references listed in identified articles and systematic reviews 
were also searched. 
Search 
The search strategy used both the search term as a keyword phrase and 
the relevant database’s subject heading where applicable. Examples of 
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search terms used were mild cognitive impairment, MCI and amnestic 
MCI (for MCI); delirium, acute confusion, acute brain dysfunction, and 
toxic psychosis (for delirium); and optical coherence tomography, RNFL, 
ganglion cell inner plexiform layer and retinal pigmented epithelium (for 
OCT). 
A more detailed description of our search strategy is included in the 
supplementary appendix. 
Study selection  
The results of application of the relevant Boolean operators and our article 
selection process is depicted in the flow charts (supplementary Figures 1 
and 2). Studies that fulfilled the inclusion criteria were selected 
independently by two reviewers (A.N. and D.A.) and any differences 
resolved by discussion with IK.M.  
Data collection process  
Data collection was performed independently by two researchers (A.N. 
and D.A.) using a piloted form. Discrepancies were jointly reviewed and 
resolved.  
Data items 
Data items were collected on article information, study design, case and 
control selection, baseline characteristics, eye and neuropsychology 
screening, exclusions, diagnostic criteria of MCI or delirium, OCT device 
used, methodology of acquiring images, signal strength, quality 
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assessment, use of APOSTEL criteria (articles after 2016),22 layers 
measured and findings.  
A detailed list of data items collected is included in the supplementary 
appendix. 
Risk of Bias in individual studies  
The Quality Assessment for Diagnostic Accuracy Studies (QUADAS)-2 tool 
was used for this review.23 Risk of bias was assessed in four domains; 
patient selection, index test, target condition and reference standard, and 
flow and timing (flow of patients through the study and timing of index 
test). Applicability was assessed in three domains; patient selection, index 
test and target condition, and reference standard. After tailoring by the 
researchers, the tool was applied independently (A.N. and D.A.) to the 
studies identified. There were no discrepancies in the individually 
performed risk of bias. 
Summary Measures 
Mean +/- SD thickness for each of the retinal layers. 
Risk of Bias across studies  
Retinal layer thickness is determined via segmentation and measurement 
by the OCT device or standalone software. Validation of these 
measurements by human graders is often performed. In order to identify 
detection bias, data were collected on whether human graders were 
blinded. In the absence of this information, it was unclear whether the 
segmentation was accepted as was from the software, in which case the 
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argument for blinding could be made, or whether human graders were 
used but not mentioned in the report. For this question in the risk of bias 
form, we made an assumption that if a human grader was not stated, 
segmentation check/adjustment was not performed, i.e. the results were 
from the software and therefore blinded. A further possible source of bias 
is the different types (time-domain vs. spectral-domain) and models of 
OCT device used across studies. To accommodate these differences, we 
analysed studies measuring retinal layers irrespective of device used and 
performed a subgroup analysis of studies using only spectral domain 
devices where there were sufficient data. Finally there was a range of 
diagnostic criteria for MCI used across studies and in some cases, lack of 
clarity about the subtype of MCI. We therefore performed a subgroup 
analysis of studies that used similar criteria for amnestic MCI.4 24 
Synthesis of results and additional analysis 
Pre-specified analyses were performed according to pathology (MCI, 
delirium) and retinal layers examined (RNFL, GCIP, macular volume). 
Meta-analysis was performed using Review Manager (RevMan 5.3) and R 
platform (version 3.5.2) for each retinal layer that had a sufficient 
number of comparable studies. Random effects analysis model was used. 
The measure of effect size was standardised mean difference (SMD) and 
the confidence interval (CI) was 95%. Higgins I2 25 was used to assess 





OCT and delirium: Of 18934 documents identified from database 
search, there were no documents relevant to OCT and delirium (see 
supplementary Figure 1).  
OCT and MCI: The database search yielded 8189 documents of which 
6188 were research articles. After screening of search results, 29 
potential articles for consideration were identified. Review of full text 
resulted in exclusion of three articles; one of which was on cognitive 
impairment no dementia (CIND), another measured retinal thickness 
using confocal scanning laser ophthalmoscopy and the third article used 
the clinical dementia rating scale (CDR) as the grouping variable. Twenty-
six articles were therefore included in this review (supplementary Figure 
2). The number of articles for each retinal layer is depicted in 
supplementary Table 1.  
Study Characteristics 
The characteristics of studies included in this review are shown in Table 1.  
Risk of bias within Studies 
The majority of studies had low or unclear risk of bias. Under-reporting in 
some aspects, e.g. sampling methods, timing between neurological 
assessment and retinal imaging, was a common theme.  
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The result of the risk of bias analysis is depicted in supplementary Figures 
3 and 4.  





Twenty-one studies17,26-45 investigated the RNFL thickness in MCI vs. 
controls. All studies prospectively collected retinal data. Participant 
sampling methods were unstated in 15 studies,17,26-33,35,37,41-43,45 
consecutive sampling in three,34,36,44 and one study each used flyer 
distribution,39 frequency matching40 and cluster sampling.38 The source of 
participants was unstated in one study41 for the MCI group and four 
studies32,37,41,43 for the control group.  
MCI 
 
Diagnostic criteria for MCI (number of studies) used were Petersen criteria 
(11),26,28,32,36-39,41-44 Albert criteria (5),29-31,40,45 Winblad criteria (2),34,35 
criteria using NIA-ADC UDS battery (1),17 and MMSE (2).27,33 Subtypes of 
MCI based on diagnostic criteria and details given in the articles included 
amnestic MCI (14),17,26,28,32,34-39,41-44 MCI due to AD – Core clinical criteria 
(3),29,31,45 MCI due to AD – Intermediate likelihood (1),40 MCI due to AD – 
Mixed [cerebrovascular disease in 63.6%, CSF Ab amyloid and tau 
positive in 50% and 25% respectively - positive being within limits of 
international normative criteria] (1),30 and amnestic MCI [no reference to 
activities of daily living] (2).27,33  
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An objective cognitive test common to both MCI group and controls was 
stated in 18 studies and not stated in three studies.31,36,41 
The time interval between neurological testing and OCT was on the same 
day in six studies,27-29,34,39,42  not stated in 14 studies,26,30-33,35-38,40,41,43-45 
and within a year (unclear) in one study. 17 
OCT 
 
Of the 21 studies, spectral-domain OCT device was used in 15 17,26,28-32,36-
40,42,44,45 and time-domain in six.27,33-35,41,43 The brands of the devices 
used included Cirrus (7),26,28,36,37,39,40,42 Stratus (6),27,33-35,41,43 Spectralis 
(5),17,29-31,38 3-D Maestro (1),44 RTVue (1),32 and custom built UHR-OCT 
(1).45 The eyes used in the different studies were mean of both eyes in 
six,26-28,39,40,42 both eyes with statistical modelling to account for paired 
eyes in three studies,17,29,34 best eye in two studies,33,35 both eyes with 
each counted as one in two studies,37,41 right eye in one study,44 right eye 
first choice in another,45 and finally one random eye in three 
studies.30,31,36 The choice of eye(s) was unstated in three studies.32,38,43 
Retinal images were centred on the optic disc in 18 studies, fovea in 
two,30,45 and not stated in one (presumed default i.e. optic disc).42 
Retinal segmentation was performed via the devices’ platform software in 
20 studies. Non-platform software was used in the remaining study.45 A 




Findings of studies 
 
After exclusion of the two studies with RNFL measurements centred on 
the fovea, there were 19 studies which reported on the mean RNFL 
thickness in MCI and controls, while 1517,26,28-30,32,34-41,43,44 reported on 
the mean RNFL thickness for optic nerve quadrants between MCI and 
controls. 
There was statistically significant reduction in the mean RNFL thickness in 
MCI compared to controls in eight studies26,27,31,33,34,41-43,45 and no 
significant reduction in 11 studies.17,28,29,32,35-40,44  
From the 15 studies that reported on RNFL quadrants, the findings are 
shown in table 2. 
Meta-analysis RNFL 
 
Meta-analysis was performed on studies that measured mean RNFL in the 
peripapillary region. Two studies30,45 which measured the RNFL at the 
fovea were excluded. A further study with retinal measurements well-
outside normative values for controls was also excluded.28 A study that 
did not provide values for retinal measurements was also excluded.35 The 
remaining 17 studies had 622 MCI cases and 1154 controls. There was 
significantly thinner mean RNFL in MCI compared to controls in this 
analysis. The standardised mean difference was -0·42 (95% CI: - 0·68 to 
-0·16) (p = 0·002). Significant heterogeneity was observed (Higgins I2 – 
82%) (Figure 1 and supplementary Figure 5). 
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RNFL in MCI compared to Controls using spectral-domain devices only 
 
A subgroup analysis was performed which included only studies using a 
spectral-domain OCT device to measure RNFL, with imaging again centred 
on the optic disc. There were 12 studies included in this analysis with 479 
participants with MCI and 986 controls. Analysis of heterogeneity yielded 
a Higgins I2 of 72%. SMD was -0·22 (95% CI of -0·46 to 0·03) (p = 0·08) 
(Figure 2). 
RNFL in amnestic MCI and Controls 
 
A further subgroup analysis was performed including only studies that 
identified participants as having amnestic MCI using Petersen or Winblad 
criteria. Thirteen studies, with 540 MCI participants and 1036 controls, 
were included in this analysis. Analysis of heterogeneity yielded a Higgins 
I2 value of 81%. SMD was –0·54 (95% CI of –0·82 to –0·26) (p = 
0·0001) (Figure 3) 
RNFL in amnestic MCI using spectral-domain OCT only 
 
Further analysis of the amnestic MCI subgroup including studies in which 
only spectral-domain OCT device was used included 8 studies on 397 MCI 
participants and 868 controls. Higgins I2 was 70%, SMD was –0·32 (95% 
CI –0·58 to –0·06) (p = 0·02) (Figure 4). 






There were nine studies on GCIP in MCI vs. controls.17,29-31,36,40,45-47 Data 
in all studies were prospectively collected. Participant sampling methods 
included consecutive in one study,36 frequency matching in another 
study,40 and was not stated in seven studies.17,29-31,45-47 While all studies 




The diagnostic criteria for MCI (number of studies) used in the studies 
included Albert criteria (7),29-31,40,45-47 Petersen criteria (1)36 and criteria 
using NIA-ADC UDS battery (scores falling 2 SD or more below mean) 
(1).17 Based on these criteria, types of MCI (number of studies) included 
MCI due to AD - Core clinical criteria (5), MCI due to AD - Intermediate 
likelihood (1), MCI due to AD - Mixed (cerebrovascular disease in 63.6%, 
CSF Ab amyloid and tau positive in 50% and 25% respectively - positive 
being within limits of international normative criteria) (1) and amnestic 
MCI (2). 
An objective cognitive test common to both MCI and control groups was 
stated in seven studies,17,29,30,40,45-47 not stated in one (used abbreviated 
mental test in controls)36 and not clearly stated in one.31 
The time interval between cognitive assessment and retinal imaging was 





All devices used were spectral-domain. Specific devices used included 
Cirrus (3),36,40,47 Spectralis (4),17,29-31 and one study each used Zeiss 
Angioplex OCTA46 and custom built UHR OCT device.45 Selection of eye(s) 
(number of studies) used included mean of both eyes (1),40 both eyes 
with statistical modelling to account for paired eyes (2),17,29 one randomly 
selected eye (3),30,31,36 one eye (right eye first choice) (2)45,46 and not 
stated in one.47 The images were centred on the fovea in eight studies 
and optic disc in one.31 Retinal segmentation was performed with platform 
software in five studies 30,36,40,46,47 and non-platform software in 
four.17,29,31,45 Manual segmentation check was performed in four studies 
17,29,36,40 and not stated in the remaining studies.30,31,45-47  
Findings of studies 
 
Of the eight studies that investigated the GCIP thickness (centred on the 
fovea) in MCI compared to controls, five studies17,29-31,40,46 found no 
significant difference and three 36,45,47 showed statistically reduced 
thickness of GCIP in MCI. Six studies looked at regional GCIP 
thickness.29,30,36,45-47 There was no significant reduction in thickness of 
regional (quadrants or sectors) GCIP in three studies29,30,46 and the 
reductions reported in the MCI group in the other three studies were as 
follows; superior quadrant,45 superior and inferonasal sectors,47 and 
superionasal, inferior and inferotemporal sectors.36  




Of the nine studies on GCIP and MCI, eight had images centred on the 
fovea. On further assessment of these, two were excluded on account of 
unclear values given for GCIP17 and values for GCIP reported as a bar 
chart.46 In the remaining six studies, GCIP was measured in an area 
defined by ETDRS circles (28·27mm2 in three studies29,30,45 and an 
elliptical annulus (14·13mm2) in the remaining studies.36,40,47 For each 
area type (ETDRS vs. elliptical annulus) we had complete data (mean and 
SD/SE) in two studies each. 29,30,36,40 The remaining two papers did not 
give a numerical value for spread of data.45,47 As a result of the limited 
number of studies with data, meta-analysis on GCIP thickness in MCI 
compared to controls was not performed.  




Five studies reported on macular thickness in people with MCI compared 
to controls 28,30,34,48,49 four of which included a measurement of mean 
foveal thickness. OCT data were collected prospectively in four studies 
and one was stated as retrospective.48 Sampling methods were not stated 
in four studies and was consecutively performed in one study.34 The 
source of cases and controls was not stated in one study.49  
MCI 
 
The diagnostic criteria for MCI (number of studies) were Petersen criteria 
(1),28 Albert criteria (1),30 Winblad criteria (1),34 memory complaints and 
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MMSE based (1),49 and DSM-IV criteria (1).48 Subtypes of MCI (number of 
studies) were amnestic MCI (3),28,34,48 amnestic MCI (no comment on 
activities of daily living) (1) 49 and MCI due to AD - Mixed 
(cerebrovascular disease in 63.6%, CSF Ab amyloid and tau positive in 
50% and 25% respectively - positive being within limits of international 
normative criteria) (1).30 
An object cognitive test common to both MCI and control groups was 
stated or alluded to in four studies. 28,30,34,49 This was not clearly stated in 
one study.48 
Time interval between cognitive assessment and OCT (number of studies) 
was on the same day (2)28,34 and not stated (3). 30,48,49 
OCT 
 
Spectral-domain devices were used in four studies. Brands of OCT device 
used were Cirrus (3),28,48,49 Spectralis30 and Stratus.34 Eye(s) used 
included both eyes (mean used) in one study,28 both eyes with each 
counted as one in one study,49 both eyes with statistical modelling to 
accommodate paired eyes in one,34 right eye only in one study48 and one 
random eye in one study.30 All studies used images centred on the fovea. 
Retinal segmentation was performed using platform software in all studies 






Macular thickness: Three of the studies found no statistically significant 
difference in macular thickness between MCI participants and 
controls.28,30,49 There was a statistically significant reduction in macular 
thickness in one study48 and a statistically significant increase in macular 
inner ring thickness in participants with MCI compared to controls in 
another.34  
Foveal thickness: Three of the studies did not find a significant 
difference in foveal thickness between participants with MCI compared to 
controls. 28,30,49 Foveal thickness was significantly higher in participants 
with MCI compared to controls in one study. 34 
Meta-analysis of foveal thickness 
 
Of the five studies, four reported values for mean foveal 
thickness.28,30,34,49 A meta-analysis was performed of mean foveal 
thickness in MCI (101 participants) vs controls (147) in these studies 
using a random effects analysis model. Analysis of heterogeneity 
measured by Higgins I2 was 79%. The SMD for the four studies was 0·05 
(95% CI -0·54 to 0·63) (Figure 5). 




Four studies investigated macular volume in people with MCI compared to 
controls.17,26,34,40 All had OCT data collected prospectively. Patient 
sampling methods were not stated in two studies,17,26 consecutive 
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sampling in one34 and one study used frequency sampling.40 Sources of 
cases and controls were stated in all studies. 
MCI 
 
The diagnostic criteria for MCI used included Petersen criteria in one 
study,26 one study each for Winblad criteria,34 criteria using NIA-ADC UDS 
battery (scores falling 2 SD or more below mean)17 and Albert criteria.40 
Subtypes of MCI included amnestic MCI in three17,26,34 and MCI due to AD 
- Intermediate likelihood in one.40 The time interval between cognitive 
testing and OCT was the same day in one study,34 not stated in two 
studies,26,40 and within a year in one study.17 There was at least one 




Spectral-domain devices were used in three17,26,40 studies. The OCT 
brands included Cirrus for two studies,26,40 and one study each for 
Spectralis,17 and Stratus.34 Mean macular volume from both eyes was 
used in two studies,26,40 and both eyes with statistical modelling to 
account for paired eyes was used in two studies.17,34 Macular volume 
measurement was achieved using the devices’ platform software in all 
studies and segmentation or measurement check using graders was 





There was no significant difference in macular volume between 
participants with MCI and controls in two studies.17,40 One study found the 
macular volume was statistically reduced in the MCI group26 and the final 
study showed macular volume was statistically increased in MCI 
compared to controls.34 Unfortunately appropriate data for analysis was 
only available for three studies17,26,40 therefore a meta-analysis of macular 
volume was not performed. 
Other retinal layers 
 
Studies on other retinal layers are briefly reviewed here. The three 
studies identified  were on choroid thickness,49 macular ganglion cell 
complex (mGCC) (internal limiting membrane to inner nuclear layer),32 
and outer retinal layers.50 The diagnoses of MCI according to the 
diagnostic criteria used were amnestic MCI32 (mGCC study), amnestic MCI 
(no comments on activities of daily living)49 (choroid thickness) and MCI 
due to AD - intermediate likelihood50 (outer retinal layers). In summary, 
the findings of these studies were significant reduction of the choroid 
thickness in the MCI group, significant reduction in the macular ganglion 
cell complex thickness in the MCI group and no significant difference in 
outer retinal layers thickness between MCI group and controls. 
Discussion 
 
Our findings support the presence of RNFL thinning and MCI, particularly 
amnestic MCI, similar to, albeit less severe, than associations between 
RNFL thinning and Alzheimer’s disease. We were unable to find any data 
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regarding delirium and retinal thickness. There was no significant 
difference between foveal thickness in MCI compared to controls on meta-
analysis of four studies. The data are unclear on any association between 
GC-IPL and MCI. The data are also unclear on the association between 
macular volume and MCI.  
To the authors’ knowledge this is the first systematic review that supports 
the finding of statistically significant thinning of the RNFL when only 
spectral domain OCT devices were used.11 12 The negative findings of 
other reviews may be due to the small number of studies included or 
perhaps a reflection of the breadth of coverage of the term ‘mild cognitive 
impairment’. 
Variability in the diagnosis and use of the term MCI has long been 
recognised and although efforts have been made to clarify diagnostic 
criteria and subtypes,4,24,51,52 consensus diagnostic criteria adopted by all 
of the research and clinical community, has yet to be achieved.  
There are significant concerns about the heterogeneity of studies included 
in this review most significantly the variations in choice and 
implementation of diagnostic criteria for MCI. To accommodate these 
differences, we performed an analysis of RNFL in people with amnestic 
MCI for all domain OCT devices (figures 3). This analysis included studies 
using Petersen criteria (10 studies) and Winblad criteria (1 study) and 
MMSE with no comments on ADLs (2 studies). A repeat analysis that 
included only studies in which amnestic MCI was diagnosed using 
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Petersen criteria yielded similar results (SMD -0.41, 95% CI -0.67 to -
0.15) albeit with less heterogeneity (I2 68%). Our analysis of RNFL in 
amnestic MCI using spectral domain devices only included studies in 
which Petersen criteria were used to diagnose amnestic MCI (figure 4).  
It cannot be overlooked that there are other factors that could impact the 
thickness of nerve layers in the retina. The studies in this review went 
some way to address this using their exclusion criteria. Performance of 
ophthalmic examinations was also stated in all but two studies. Close 
review of the exclusion criteria revealed that while the presence of 
diseases associated with macular thinning such as glaucoma and age-
related macular degeneration were consistently excluded, more subtle 
confounders such as axial length or refractive error were more sporadic 
considerations.   
Other differences between studies included variations in retinal image 
acquisition, e.g. device used, choice of eye and area in retina imaged, and 
software packages used to measure retinal layers. 
There is evidence that retinal measurements are not reproducible 
between different segmentation and measurement platforms.53,54 This has 
been ascribed to differing segmentation algorithms however Folgar53 
showed that even in different models of OCT device made by the same 
manufacturer, the differences in measurements persisted, albeit to a 
lesser degree. In addition, normal values for the thickness of retinal 
layers vary with ethnicity55,56 bringing into question the appropriateness 
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of combining the data from different ethnic groups. A further concern of 
ours is the variability in selection of eye(s). Two studies37,41 obtained 
retinal layer measurements from both eyes and counted them as 
individual units. This  may have been an effort to increase the number of 
data points however the fact that a pair of eyes are correlated cannot be 
overlooked.57 
There is also the problem of the older person defined as aged ≥ 65 years 
old. Normative data for RNFL thickness in this age group covers a broad 
range. The RNFL thickness has previously been reported to be reduced by 
approximately 1.5 µm55 to 2 µm58 per decade. Age matching between 
groups, as occurred in the majority of articles in this review, may reduce 
this effect. 
As previously mentioned, axial length and optic disc area may impact on 
the thickness of the RNFL.58 These were not factored in in the studies 
reviewed. 
The association between RNFL and MCI may have diagnostic benefits for 
patients. There is scope for future studies to assess the additional 
diagnostic power of adding OCT measurement to existing clinical criteria. 
Similarly, long-term follow-up may elucidate whether RNFL thinning is a 
biomarker of subsequent dementia following MCI.  
In summary, there are no data on the possible association between 
retinal OCT measurements and the occurrence of delirium. Despite 
significant study heterogeneity and study design issues, there appears to 
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be a relationship between MCI, particularly amnestic MCI, and retinal 
nerve fibre layer thickness. A lack of sufficient studies prevents 
conclusions about other OCT based retinal measurements.  
Conclusion 
 
There may be a role for retinal assessment using OCT in the assessment 
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Figure 1: Forest plot of RNFL centred on the optic disc measured using 
any domain OCT device comparing MCI to controls. 
Figure 2: Forest plot of RNFL centred on the optic disc measured with 
spectral domain OCT comparing MCI to controls. 
Figure 3: Forest Plot of RNFL measured using any domain OCT device 
comparing amnestic MCI to controls 
Figure 4: Forest plot of RNFL measured using spectral domain OCT device 
comparing amnestic MCI to controls 
Figure 5: Forest plot of foveal mean thickness as measured using OCT in 
MCI vs Controls. 
 
Supplementary Appendix legend 
 
One supplementary appendix with the following contents: 
• Search strategy with example 
• List of data items collected from individual studies 
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• Supplementary figure 1: PRISMA flow diagram of study selection: 
optical coherence tomography and delirium 
• Supplementary figure 2: PRISMA flow diagram of study: selection 
for optical coherence tomography and mild cognitive impairment 
• Supplementary figure 3: Risk of Bias and applicability concerns 
summary: review authors’ judgements about each domain for each 
included study 
• Supplementary figure 4: Risk of Bias and applicability concerns 
graph: review authors’ judgements about each domain presented as 
percentages across included studies 
• Supplementary figure 5: Funnel plot of studies included in the 
meta-analysis of RNFL thickness centred on the optic disc in MCI 
compared to controls 









Table 1: Characteristics of articles included in this review. 
 


























































































































































































































































































































































Abbreviations: MCI = mild cognitive impairment, OCT = optical coherence 
tomography, Retro. = retrospective, RNFL = retinal nerve fibre layer, 
GCIP = ganglion cell inner plexiform layer, mGCC = macular ganglion cell 
complex, ADL = activities of daily living, NIA-ADC = National Institute on 
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Abbreviations: RNFL = Retinal Nerve Fibre Layer, MCI = Mild Cognitive 
Impairment  
